AKAN

Akanda Corp.

$0.74

-8.85%

SectorHealthcareIndustryDrug Manufacturers - Specialty & GenericCountryCanada

Overview AI Brief ChartChart & Performance Financials ExposureRevenue Exposure FilingsFilings & Red Flags ScoresScores & Valuation News Analysts InsidersInsiders & Short Interest Ownership

Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers. The company is based in Toronto, Canada.

Source: Yahoo Finance

Market Cap$1.9M

Dividend Yield0.00%

Beta1.50

AI summary

Price & performance

1M-55.9%

3M-87.5%

YTD-89.2%

1Y-97.6%

52-week range—

Beta1.50

Full chart and returns against a benchmark

Q-Score

11/ 100

Quality against peers; 50 is the peer median.

Growth27

Risk16

Performance17

Valuation29

Profitability22

Leverage20

Sentiment—

Every score and metric

News sentiment

Open News

Latest results · FY 2024

Revenue$836.7K+97.5%

Net income-$4.1M

Net margin-489.6%

Historical fundamentals

Red flags in filings

3active red flags

Going-concern doubtJun 9, 2026

Material weakness in controlsJun 9, 2026

Late filing noticeMay 1, 2026

Filings, findings and the timeline

Revenue exposure

Regions, segments, customers and suppliers

Valuation

AKANIndustryP/E—35.25P/S2.332.74EV/EBITDA—16.35P/B0.592.46PEG—0.87

Dividend yield0.00%

Every valuation metric

Historical Fundamentals

Revenue

Net Income

Net Margin

Showing the last 4 periods. Pro adds the full annual and quarterly history and 20+ more metrics to chart.

Latest Results

The latest fiscal year and quarter, each against the same period a year earlier, from SEC filings.

Metric	FY 2024	vs a year before	Q2 2025	vs a year before
Revenue	$836.7K	+97.5%	—	—
Net Income	-$4.1M	—	—	—
Net Margin	-489.6%	—	—	—

Q-Scores

OverallCombines the categories below, except Sentiment

Industry 5911

Growth

Industry 6627

Risk

Industry 6816

Performance

Industry 5917

Valuation

Industry 4929

Profitability

Industry 4922

Leverage

Industry 4420

Key Metrics

Fundamentals: trailing twelve months to Jun 2025, from the latest 10-K and 10-Qs.

Market Beta (5-factor)

IM 0.76SM 0.781.27

Market Cap

1.9M

Dividend Yield

IM 0.00%SM 0.00%0.00%

Volume

IM 1MSM 741.7K1.4M

Industry Market Share

0.00%

Sector Market Share

0.00%

IM industry median · SM sector median: the typical company the value is compared with. The /100 is its score against those peers.

Comparable Companies

The companies closest in size in Drug Manufacturers - Specialty & Generic (filled from its sector when there are few), with the median and rank across all 82 in the industry.

Company	Market cap	P/S	P/B	FCF yield	Revenue growth	Op. margin	ROE	Debt/equity
AKANAkanda Corp.	$1.9M	2.3	0.6	-198.2%	8.4%	-443.8%	-67.5%	0.1
SBFMSunshine Biopharma, Inc.	$2.2M	0.1	0.1	-247.7%	-2.7%	-16.6%	-21.2%	0.0
PRFXPRF Technologies Ltd.	$2.8M	164.0	0.3	-141.9%	—	—	-58.8%	0.0
RDHLRedHill Biopharma Ltd.	$3.3M	0.3	—	-246.3%	157.6%	-110.4%	—	—
IMCCIM Cannabis Corp.	$1M	0.0	—	340.6%	6.1%	-21.2%	—	—
APUSApimeds Pharmaceuticals US, Inc.	$4.1M	—	0.0	-328.4%	—	—	-54.6%	0.0
GELSGelteq Limited	$4.5M	41.6	0.4	-80.2%	—	—	-42.0%	0.3
YCBDcbdMD, Inc.	$5.2M	0.2	0.6	-46.7%	10.0%	-13.9%	-35.2%	0.0
SNOASonoma Pharmaceuticals, Inc.	$5.5M	0.2	0.8	-48.6%	47.0%	-6.4%	-34.3%	0.0
Industry median		1.9	1.7	0.1%	8.9%	-7.1%	-14.9%	0.0
AKAN percentile		59th	19th	4th	47th	2nd	15th	52nd